What is it about?
The clinical and therapeutic implications for the ADHD-ASD co-occurrence are discussed. A unified description of NDEBID would buttress their common aetiologies. This would also encourage practitioners not to restrict individuals into constrained diagnostic boxes but to consider the full range of their difficulties, even if they do not meet the seemingly arbitrary threshold levels for diagnosis of the individual conditions.Further research is needed to help analyse important peculiar neuropsychological features among individuals with the co-occurring ASD/ADHD features.
Featured Image
Why is it important?
Co-occurrence of NDD and related emotional, behavioural and intellectual disabilities, associated with multi-domain functional impairment is recognised as the norm rather than the exception. Researchers are increasingly drawing attention to the almost ubiquitous occurrence of comorbidity among patients with NDD. All NDD often present with common neurodevelopmental features outside their diagnostic criteria such as communication, language and motor disorders. Neurocognitive executive functional impairments such as impaired working memory and planning are also almost invariably universal components of many NDD, particularly ADHD and ASD.
Perspectives
There is increasing published evidence to support the paradigm of making a single diagnosis of severe ASD with co-occurring ADHD symptoms or more generic description of a wider range of symptoms associated with any NDEBID, as highlighted in this review. It is conceivable that this would likely provide a better understanding for many CYP with apparent comorbid diagnoses. Some advantages to this approach include realisation that a modified approach to treatment should be explored and encouragement of further research.
Dr Michael O Ogundele
Mid Cheshire Hospitals NHS Foundation Trust Postgraduate Medical Centre
Read the Original
This page is a summary of: Conceptualisation Paradigms for Childhood Autism and ADHD Co-occurrence: A Brief Review and Clinical Implications, European Journal of Therapeutics, February 2025, Yeni Uroloji Dergisi,
DOI: 10.58600/eurjther2502.
You can read the full text:
Contributors
The following have contributed to this page
